Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Steven M. Kornblau, MD, Chenyu W Hu, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Tapan M. Kadia, MD, Alessandra Ferrajoli, MD, Kevin R. Coombes, PhD, Amina A Qutub, PhD

Blood (2013) 122 (21): 1337.

https://doi.org/10.1182/blood.V122.21.1337.1337

Published: 2013

Journal Articles

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

Erel Joffe, MD MSc, Kevin R. Coombes, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Elmer V Bernstam, MD MS, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1728.

https://doi.org/10.1182/blood.V122.21.1728.1728

Published: 2013

Journal Articles

High p53 Protein Expression LEVEL Independent Of Mutational Status Is An Adverse Prognostic Factor For Survival In ACUTE Myeloid Leukemia

Alfonso Quintas-Cardama, MD, Sean M. Post, PhD, Kensuke Kojima, MD, PhD, Yi Hua Qiu, MD, Michael Andreeff, MD, PhD, Carlos E. Bueso-Ramos, MD, PhD, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1330.

https://doi.org/10.1182/blood.V122.21.1330.1330

Published: 2013

Journal Articles

BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses

Raoul Tibes, MD, PhD, Steven M. Kornblau, MD, William E. Pierceall, PhD, Ryan Lena, BS, Yi Hua Qiu, MD, Michael Cardone, PhD, Leena Chaudhuri, PhD, Veena Fauble, MD, Michael Elashoff, Noel Blake, B.S., Ruben A. Mesa, MD, James M Bogenberger, PhD

Blood (2013) 122 (21): 603.

https://doi.org/10.1182/blood.V122.21.603.603

Published: 2013

Journal Articles

Prognostic impact and targeting of CRM1 in acute myeloid leukemia

Kensuke Kojima, Steven M. Kornblau, Vivian Ruvolo, Archana Dilip, Seshagiri Duvvuri, R. Eric Davis, Min Zhang, Zhiqiang Wang, Kevin R. Coombes, Nianxiang Zhang, Yi Hua Qiu, Jared K. Burks, Hagop Kantarjian, Sharon Shacham, Michael Kauffman, Michael Andreeff

Blood (2013) 121 (20): 4166–4174.

https://doi.org/10.1182/blood-2012-08-447581

Published: 2013

Includes: Supplemental data

Journal Articles

hnRNP K: A Putative Regulator of Leukemogenesis and the p53 Pathway

Alfonso Quintas-Cardama, MD, Xiaorui Zhang, Youmna Attieh, Hun Ju Lee, MD, Yi Hua Qiu, MD, Steven M. Kornblau, MD, PhD, Sean Post

Blood (2012) 120 (21): 774.

https://doi.org/10.1182/blood.V120.21.774.774

Published: 2012

Journal Articles

Prognostic Impact and Targeting of CRM1 in Acute Myeloid Leukemia

Kensuke Kojima, MD, PhD, Steven M. Kornblau, MD, PhD, Vivian Ruvolo, Seshagiri Duvvuri, Richard E Davis, MD, Min Zhang, Ph.D., Zhiqiang Wang, Ph.D., Kevin R. Coombes, PhD, Nianxiang Zhang, Yi Hua Qiu, MD, Jared K. Burks, Peter P. Ruvolo, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, Ph.D., Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 870.

https://doi.org/10.1182/blood.V120.21.870.870

Published: 2012

Journal Articles

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

Rui-yu Wang, MD, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Teresa McQueen, BS, Ye Chen, PhD, Zhihong Zeng, MD, Kevin R. Coombes, PhD, Wendy D. Schober, MLT (ASCP), Marina Konopleva, MD, PhD, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 2355.

https://doi.org/10.1182/blood.V120.21.2355.2355

Published: 2012

Journal Articles

High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia

Alfonso Quintás-Cardama, MD, Yi Hua Qiu, MD, Sean Post, Steven M. Kornblau, MD

Blood (2011) 118 (21): 1490.

https://doi.org/10.1182/blood.V118.21.1490.1490

Published: 2011

Journal Articles

Proteomic Profiling of 112 Proteins in Chronic Myeloid Leukemia Patient Samples Using Reverse Phase Proteins Arrays (RPPA) Reveals Distinct Protein Expression Signatures Associated with Advanced Phase Disease and the CD34+ Compartment

Alfonso Quintás-Cardama, MD, Yi Hua Qiu, MD, Sean Post, Yiqun Zhang, Chad Creighton, Jorge E. Cortes, Steven M. Kornblau, MD

Blood (2011) 118 (21): 2503.

https://doi.org/10.1182/blood.V118.21.2503.2503

Published: 2011

Journal Articles

High Expression of Autophagy Related Proteins Negatively Impacts Clinical Outcomes in Acute Myelogenous Leukemia–Time to Target Autophagy to Improve Therapy Outcomes?

Gautam Borthakur, Michael Andreeff, M.D., Ph.D., Kevin R Coombes, Yi Hua Qiu, MD, Seshagiri Duvvuri, Nianxiang Zhang, Vivian Ruvolo, Marina Konopleva, MD, PhD, Guillermo Garcia-Manero, Peter P. Ruvolo, PhD, Jorge E. Cortes, Hagop M. Kantarjian, Steven M. Kornblau, MD

Blood (2011) 118 (21): 2513.

https://doi.org/10.1182/blood.V118.21.2513.2513

Published: 2011

Journal Articles

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Steven M. Kornblau, Yi Hua Qiu, Nianxiang Zhang, Neera Singh, Stefan Faderl, Alessandra Ferrajoli, Heather York, Amina A. Qutub, Kevin R. Coombes, Dennis K. Watson

Blood (2011) 118 (20): 5604–5612.

https://doi.org/10.1182/blood-2011-04-348052

Published: 2011

Includes: Supplemental data

Journal Articles

Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML

Bing Z. Carter, Yi Hua Qiu, Nianxiang Zhang, Kevin R. Coombes, Duncan H. Mak, Deborah A. Thomas, Farhad Ravandi, Hagop M. Kantarjian, Erich Koller, Michael Andreeff, Steven M. Kornblau

Blood (2011) 117 (3): 780–787.

https://doi.org/10.1182/blood-2010-04-280503

Published: 2011

Includes: Supplemental data

Journal Articles

Abnormal Expression of Friend Leukemia Virus Integration 1 (Fli1) Protein Is An Adverse Prognostic Factor In AML.

Steven M. Kornblau, MD, Yi Hua Qiu, MD, Nianxiang Zhang, Ph.D, Kevin R Coombes, Dennis K. Watson, BS, PhD

Blood (2010) 116 (21): 1674.

https://doi.org/10.1182/blood.V116.21.1674.1674

Published: 2010

Journal Articles

Epidermal Growth Factor Receptor Expression and Activity In Acute Myeloid Leukemia

Arja ter Elst, Steven M. Kornblau, MD, Frank jg Scherpen, Yi Hua Qiu, MD, Nianxiang Zhang, Kevin R Coombes, Evelina S. De Bont, MD, PhD

Blood (2010) 116 (21): 3144.

https://doi.org/10.1182/blood.V116.21.3144.3144

Published: 2010

Journal Articles

Proteomic Profiling of 128 Proteins In 194 Acute Lymphocytic Leukemia (ALL) Patients Using Reverse Phase Proteins Arrays (RPPA) Reveals Recurrent Proteins Expression Signatures with Prognostic Implications

Steven M. Kornblau, MD, Yi Hua Qiu, MD, Nianxiang Zhang, Kevin R Coombes, Susan O'Brien, Hagop M. Kantarjian, MD, Deborah A Thomas, MD

Blood (2010) 116 (21): 3230.

https://doi.org/10.1182/blood.V116.21.3230.3230

Published: 2010

Journal Articles

Effect of FLT3 and RAS Mutations on Protein Expression Patterns In Cases of Acute Myelogenous Leukemia (AML) with NPM1 Mutations

Steven M. Kornblau, MD, Yujia Huo, BS, Mark Brandt, Nianxiang Zhang, Ph.D, Yi Hua Qiu, MD, Farhad Ravandi, MD, Tapan Kadia, MD, Pierce Sherry, Kevin R Coombes, Ph.D, Hagop M. Kantarjian, MD

Blood (2010) 116 (21): 2704.

https://doi.org/10.1182/blood.V116.21.2704.2704

Published: 2010

Journal Articles

Proteomic Profiling In CD34+CD38- Stem Cells and CD34+ Cells From 185 Myelodysplasia Patients Using Reverse Phase Proteins Arrays (RPPA) Reveals Recurrent Proteins Expression Signatures with Prognostic Implications

Steven M. Kornblau, MD, Yi Hua Qiu, MD, Nianxiang Zhang, Kevin R Coombes, David Graber, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD

Blood (2010) 116 (21): 2126.

https://doi.org/10.1182/blood.V116.21.2126.2126

Published: 2010

Journal Articles

Functional proteomic profiling of AML predicts response and survival

Steven M. Kornblau, Raoul Tibes, Yi Hua Qiu, Wenjing Chen, Hagop M. Kantarjian, Michael Andreeff, Kevin R. Coombes, Gordon B. Mills

Blood (2009) 113 (1): 154–164.

https://doi.org/10.1182/blood-2007-10-119438

Published: 2009

Includes: Supplemental data

Journal Articles

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

Steven M. Kornblau, Matthew Womble, Yi Hua Qiu, C. Ellen Jackson, Wenjing Chen, Marina Konopleva, Elihu H. Estey, Michael Andreeff

Blood (2006) 108 (7): 2358–2365.

https://doi.org/10.1182/blood-2006-02-003475

Published: 2006

Includes: Supplemental data

NARROW

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

High p53 Protein Expression LEVEL Independent Of Mutational Status Is An Adverse Prognostic Factor For Survival In ACUTE Myeloid Leukemia

BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses

Prognostic impact and targeting of CRM1 in acute myeloid leukemia

hnRNP K: A Putative Regulator of Leukemogenesis and the p53 Pathway

Prognostic Impact and Targeting of CRM1 in Acute Myeloid Leukemia

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia

Proteomic Profiling of 112 Proteins in Chronic Myeloid Leukemia Patient Samples Using Reverse Phase Proteins Arrays (RPPA) Reveals Distinct Protein Expression Signatures Associated with Advanced Phase Disease and the CD34+ Compartment

High Expression of Autophagy Related Proteins Negatively Impacts Clinical Outcomes in Acute Myelogenous Leukemia–Time to Target Autophagy to Improve Therapy Outcomes?

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML

Abnormal Expression of Friend Leukemia Virus Integration 1 (Fli1) Protein Is An Adverse Prognostic Factor In AML.

Epidermal Growth Factor Receptor Expression and Activity In Acute Myeloid Leukemia

Proteomic Profiling of 128 Proteins In 194 Acute Lymphocytic Leukemia (ALL) Patients Using Reverse Phase Proteins Arrays (RPPA) Reveals Recurrent Proteins Expression Signatures with Prognostic Implications

Effect of FLT3 and RAS Mutations on Protein Expression Patterns In Cases of Acute Myelogenous Leukemia (AML) with NPM1 Mutations

Proteomic Profiling In CD34+CD38- Stem Cells and CD34+ Cells From 185 Myelodysplasia Patients Using Reverse Phase Proteins Arrays (RPPA) Reveals Recurrent Proteins Expression Signatures with Prognostic Implications

Functional proteomic profiling of AML predicts response and survival

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only